Navigation Links
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
Date:3/11/2008

-current portion of equipment

financing 1,352,684 955,695

Deferred rent and other non-current

liabilities 1,576,734 1,464,902

Total liabilities 11,851,683 12,472,671

Commitments

Stockholders' equity:

Common stock 3,437 2,944

Additional paid-in capital 320,579,240 298,073,896

Deferred stock-based compensation (251,601) (1,006,604)

Accumulated other comprehensive

income (loss) 69,262 (21,376)

Accumulated deficit (279,006,083) (240,245,163)

Total stockholders' equity 41,394,255 56,803,697

Total liabilities and stockholders'

equity $53,245,938 $69,276,368

Note 1: The condensed balance sheet at December 31, 2006 has been

derived from the audited financial statements at that date

included in the Company's Form 10-K for the fiscal year ended

December 31, 2006.

SUNESIS PHARMACEUTICALS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

Three months ended Twelve months ended

December 31, December 31,

2007 2006 2007 2006

Revenue:

Collaboration

revenue $37,500 $229,167 $1,576,610 $6,353,585

Collaboration

revenue from

related party 1,759,208 1,725,810 7,586,903 7,317,700

License revenue 250,000 - 500,000 -

Grant and

fellowship

revenue
'/>"/>

SOURCE Sunesis Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
2. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
3. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
4. Sunesis Pharmaceuticals to Report Third Quarter 2007 Financial Results
5. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
6. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
7. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
8. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
9. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
10. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008
11. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013 Express Diagnostics Int’l, Inc., ... announced that it has received Class III medical device ... its DrugCheck® NxStep Onsite Drug Screen Cup ... rapid screening device in near-patient settings, such as physicians’ ... received Health Canada Class III approval for 24 different ...
(Date:6/18/2013)... In support of Swiss contributions to scientific ... Switzerland in New York is pleased to welcome the ... , to Manhattan. PlanetSolar is in New York ... with scientists on board from the University of Geneva. ... on energy from the sun and eliminates the need ...
(Date:6/18/2013)... June 18, 2013 DuPont welcomes 48 ... 11th annual DuPont National AgriScience Teachers Ambassador Academy this ... in Chestertown, Md. , The NATAA “Ag ... and is a special project of the National ... Agricultural Educators (NAAE) . The highly recommended agriscience ...
(Date:6/18/2013)... June 18, 2013 ... research firm, announces the initiation of full ... biopharmaceutical company developing and marketing products for ...      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... examining the investment merits of BioAlliance Pharma, ...
Breaking Biology Technology:Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3
... Every year, millions of people contend with lower back ... Cornell University engineers in Ithaca and doctors at the ... created a biologically based spinal implant that could someday ... Bonassar, Ph.D., associate professor of biomedical engineering and mechanical ...
... health condition that can lead to damaged heart tissue ... peripheral arterial disease in limbs, amputation, particularly in diabetic ... novel nanostructure that promotes the growth of new blood ... where increased blood flow is needed to supply oxygen ...
... Flexible, transparent electronics are closer to reality with the ... The lab of Rice chemist James Tour lab has ... panels and LED lighting. The research was reported in ... Flexible, see-through video screens may be the "killer app" ...
Cached Biology Technology:In the battle to relieve back aches, Cornell researchers create bioengineered spinal disc implants 2In the battle to relieve back aches, Cornell researchers create bioengineered spinal disc implants 3Restoring blood flow 2Restoring blood flow 3Dream screens from graphene 2Dream screens from graphene 3
(Date:6/18/2013)... Council, Laboratory of Molecular Biology, has been honored ... Investigator Award. Torrent is being recognized for his ... to predict antimicrobial regions in proteins. Luis Rivas, ... applying this algorithm to interrogate full genomes in ... very appealing results." , Torrent obtained his ...
(Date:6/18/2013)... extract of a yellow-flowered mountain plant long used for ... fruit fly populations by an average of 24 percent, ... Rhodiola rosea , also known as ... study leaders Mahtab Jafari and Sam Schriner. They discovered ... unrelated to dietary restriction and affects different molecular pathways. ...
(Date:6/18/2013)... shows that weight gain and increased head size in the ... IQ at early school age. , The study was led by ... than 13,800 children who were born full-term. , The results, published ... who put on 40% of their birthweight in the first four ... were six years of age, compared with babies who only put ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Marc Torrent 2Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2IQ link to baby's weight gain in first month 2
... carrot has been produced to help people absorb more calcium. ... Improvement Center studied the calcium intake of humans who ate ... The research, which was done in collaboration with Baylor College ... help prevent such diseases as osteoporosis. If you ...
... UBC researchers have discovered some of the genetic ... fight off pests and disease, uncovering critical new ... Prof. Joerg Bohlmann says this genetic analysis will ... inherent strength, breeding trees that could in time ...
... 14, 2008) Reporting in the online journal BMC Genetics, ... attempted to count the number of genes that contribute to ... over 6,000 genes about 25 percent of the genome ... describing the discovery of a new obesity gene have become ...
Cached Biology News:Got carrots? Vegetables may have bone to pick as calcium providers 2UBC discovery unlocks tree genetics, gives new hope for pine beetle defense 2Body weight influenced by thousands of genes 2
... The super cooling coil, ... for native enzyme, high-intensity, and ... performed with the Trans-Blot cell. ... coil requires connection to an ...
... By incorporating a wide range of ... NX sets a new standard for flexible ... liquid handling including pipetting, dilution, dispensing, ... system thats as powerful and flexible as ...
... The Biomek FX P is ... an,up-to-date hardware design for greater positional accuracy and ... just about any application. It can be configured ... its large deck capacity, the Biomek FX P ...
These Costar 96-well, flat-bottom polystyrene EIA plates are used for EIAs, ELISAs, and other protein binding assays. Supplied as box of 100 (20 packages; 5 plates per package)....
Biology Products: